Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT05687721Phase 1/2Withdrawn
Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer
Advanced Urothelial Carcinoma
PrincipalinvestigatorStart date: 2025-06-02
NCT05519241Phase 1Recruiting
A Phase I Intravesical PPM Therapy for NMIBC
Non-muscle-invasive Bladder Cancer
PrincipalinvestigatorStart date: 2022-10-10
NCT07793578Phase 1/2Not Yet Recruiting
Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer
Advanced Urothelial Carcinoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Doug Warner

Tyra Biosciences, Inc

Moderately Similar
3 trials

Shared therapeutic areas:

Advanced Urothelial CarcinomaNon-Muscle Invasive Bladder Neoplasms
Similarity Score30%

Ahmed A. Shokeir

Urology and Nephrology Center, Mansoura University, Egypt

Related
2 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Francesco Montorsi, MD

IRCCS Ospedale San Raffaele

Related
4 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Hailong Li, M.D/Ph.D

The Affiliated Hospital of Xuzhou Medical University

Related
3 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Lisa Franklin

Istari Oncology

Related
3 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Bernard Bochner, MD

Memorial Sloan Kettering Cancer Center

Related
4 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Hassan Abol-Enein, MD, Phd

Urology and Nephrology Center

Related
2 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Hassan Abol-Enein, MD

Urology and Nephrology center

Related
3 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Yair Lotan, MD

University of Texas Southwestern Medical Center

Related
10 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Junnian Zheng, M.D/Ph.D

The Affiliated Hospital of Xuzhou Medical University

Related
3 trials

Shared therapeutic areas:

Non-Muscle Invasive Bladder Neoplasms
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05687721Phase 1/2PrincipalInvestigator

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

Advanced Urothelial Carcinoma
Withdrawn
NCT05519241Phase 1PrincipalInvestigator

A Phase I Intravesical PPM Therapy for NMIBC

Non-muscle-invasive Bladder Cancer
Recruiting
NCT07793578Phase 1/2PrincipalInvestigator

Immunotherapy Plus Capivasertib for Metastatic Bladder Cancer

Advanced Urothelial Carcinoma
Not Yet Recruiting

All 3 trials loaded